Search results
This study found that the overall risk of breast cancer among hormonal contraceptive users is low. Because of the low baseline risks in the age groups using hormonal contraception (ie, premenopausal women), the risk difference between hormonal contraception users and nonusers is small.
1 mar 2021 · There is limited data on hormonal contraceptive use in breast cancer survivors. • Hormonal contraceptives may not increase the risk of breast cancer recurrence. • All-cause mortality did not differ among hormonal contraceptive users and non-users.
18 paź 2009 · This paper reviews the evidence supporting the safety and efficacy of available methods of contraception for cancer survivors and concludes that the Copper T380A intrauterine device (IUD), a highly effective, reversible, long-acting, hormone-free method should be considered a first-line contraceptive option for women with a history of a hormonal...
Abstract. Introduction: Epidemiological studies have shown that some hormonal contraceptive methods are associated with increased breast cancer risk, especially if used over long periods.
Findings In this cohort study of 2900 premenopausal women with early breast cancer enrolled in the prospective Cancer Toxicity study, 54.2% of patients reported contraceptive use at the time of diagnosis, with most patients using hormonal methods. Contraceptive use significantly decreased after primary treatment and during follow-up, when most ...
4 lip 2024 · Mirena is an intrauterine device (IUD) for birth control. Because it's a type of hormonal contraception, it could slightly increase your chances of getting breast cancer.
6 dni temu · A new study has found a link between hormonal intrauterine devices (IUDs) and breast cancer. But media reports of a large increase in risk may cause unnecessary worry.
